Viatris Tipped To Knock Out Crucial Eylea Dosing Patents In US

Lower Preponderance-Of-The-Evidence Standard May Favor Mylan

 
• By Dean Rudge
  
US flag gavel (Andriy Popov/Alamy Stock Photo)
A decision is due later this year • Source: Shutterstock (Andriy Popov / Alamy Stock Photo/Alamy Stock Photo)
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products